Proceedings of the National Academy of Sciences · 2000 · 648 citations · 35 references
MedicineGeneticsMolecular GeneticsCellular PathologyMedical GeneticsMolecular PathologyPulmonary PathologyTuberous Sclerosis ComplexCommon Genetic VariantsMutationRenal AngiomyolipomaSomatic MutationsTsc2 GeneTsc2 MutationsTuberous Sclerosis Complex GeneticsYoung Women
Lymphangioleiomyomatosis is a fatal interstitial lung disease of young women characterized by diffuse proliferation of abnormal smooth muscle cells, occurring sporadically or with tuberous sclerosis complex, and frequently associated with renal angiomyolipomas, suggesting a shared genetic basis. The study aimed to identify somatic TSC2 mutations in angiomyolipomas from sporadic LAM patients. Somatic TSC2 mutations were detected in most angiomyolipomas and the corresponding pulmonary smooth muscle cells of sporadic LAM patients, but not in normal tissues, confirming a direct role of TSC2 in disease pathogenesis.
Lymphangioleiomyomatosis (LAM) is a progressive and often fatal interstitial lung disease characterized by a diffuse proliferation of abnormal smooth muscle cells in the lungs. LAM is of unusual interest biologically because it affects almost exclusively young women. LAM can occur as an isolated disorder (sporadic LAM) or in association with tuberous sclerosis complex. Renal angiomyolipomas, which are found in most tuberous sclerosis patients, also occur in 60% of sporadic LAM patients. We previously found TSC2 loss of heterozygosity in 7 of 13 (54%) of angiomyolipomas from sporadic LAM patients, suggesting that LAM and TSC could have a common genetic basis. In this study, we report the identification of somatic TSC2 mutations in five of seven angiomyolipomas from sporadic LAM patients. In all four patients from whom lung tissue was available, the same mutation found in the angiomyolipoma was present in the abnormal pulmonary smooth muscle cells. In no case was the mutation present in normal kidney, morphologically normal lung, or lymphoblastoid cells. Our data demonstrate that somatic mutations in the TSC2 gene occur in the angiomyolipomas and pulmonary LAM cells of women with sporadic LAM, strongly supporting a direct role of TSC2 in the pathogenesis of this disease.
35
Identification of the Tuberous Sclerosis Gene <i>TSC1</i> on Chromosome 9q34
Marjon van Slegtenhorst, Ronald De Hoogt, Caroline Hermans et al. · Science · 1997 · 1.7K citations
Causes of Death in Patients With Tuberous Sclerosis
C. W. Shepherd, Manuel R. Gómez, J. T. Lie et al. · Mayo Clinic Proceedings · 1991 · 562 citations
James R. Taylor, Jay H. Ryu, Thomas V. Colby et al. · New England Journal of Medicine · 1990 · 464 citations · Full text
Medicine, Cell Biology, Pathology +10